3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Peritoneal Neoplasms
9
Colorectal Neoplasms
8
Appendiceal Neoplasms
7
Stomach Neoplasms
5
Ovarian Neoplasms
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Pseudomyxoma Peritonei
2
Neoplasm Metastasis
2
Peritoneal Diseases
1
Necrosis
1
Mesothelioma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
pembrolizumab
9
Nivolumab
5
fludarabine
4
Cyclophosphamide
4
amatuximab
3
Ipilimumab
3
Fluorouracil
3
Cisplatin
3
tislelizumab
2
spartalizumab
2
budigalimab
2
belinostat
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cytoreduction Surgical Procedures
2
Carboplatin
2
venetoclax
1
talazoparib
1
rovalpituzumab tesirine
1
ribociclib
1
rebastinib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
epacadostat
1
durvalumab
1
bosutinib
1
atezolizumab
1
aldesleukin
1
Valacyclovir
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma
×
Mitomycin
×
Gynecologic
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled